Epidemiology of rotavirus in infants and protection against symptomatic illness afforded by primary infection and vaccination

Author： Mrukowicz J.Z. Thompson J. Reed G.W. Tollefson S.J. Kobayashi M. Araki K. Wright P.F.

Publisher： Elsevier

ISSN： 0264-410X

Source： Vaccine, Vol.17, Iss.7, 1999-02, pp. : 745-753

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Protection against influenza virus infection by nasal vaccination in advance of sublethal irradiation

By Hasegawa H. Kadowaki S.-e. Takahashi H. Iwasaki T. Tamura S.-i. Kurata T.

Vaccine, Vol. 18, Iss. 23, 2000-05 ,pp. : 2560-2565

Elsevier

Access to resources Recommend Favorite

Protection of cattle against Fasciola hepatica infection by vaccination with glutathione S-transferase

By Morrison C.A. Colin T. Sexton J.L. Bowen F. Wicker J. Friedel T. Spithill T.W.

Vaccine, Vol. 14, Iss. 17, 1996-12 ,pp. : 1603-1612

Elsevier

Access to resources Recommend Favorite

Mucosal vaccination with recombinant poxvirus vaccines protects ferrets against symptomatic CDV infection

By Welter J. Taylor J. Tartaglia J. Paoletti E. Stephensen C.B.

Vaccine, Vol. 17, Iss. 4, 1999-02 ,pp. : 308-318

Elsevier

Access to resources Recommend Favorite

DNA vaccination with linear minimalistic (MIDGE) vectors confers protection against Leishmania major infection in mice

By Lopez-Fuertes L. Perez-Jimenez E. Vila-Coro A.J. Sack F. Moreno S. Konig S.A. Junghans C. Wittig B. Timon M. Esteban M.

Vaccine, Vol. 21, Iss. 3, 2002-12 ,pp. : 247-257

Elsevier

Access to resources Recommend Favorite

Protection against Leishmania donovani infection by DNA vaccination: increased DNA vaccination efficiency through inhibiting the cellular p53 response

By Ghosh A. Labrecque S. Matlashewski G.

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3169-3178

Elsevier

Access to resources Recommend Favorite